Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Finasteride and minoxidil together work best for male hair loss.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Melatonin solution helps treat hair loss in men and women.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

UBM helps hair regrowth in men and women with hair loss.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Minoxidil effectively treats patterned hair loss in both males and females.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

New compounds may soon be tested to treat excessive hair growth in women.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.